{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:14:19Z","timestamp":1794006859163,"version":"4.8.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007700","name":"Miami Center for AIDS Research","doi-asserted-by":"publisher","award":["P30AI073961"],"award-info":[{"award-number":["P30AI073961"]}],"id":[{"id":"10.13039\/100007700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA240139"],"award-info":[{"award-number":["P30CA240139"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","award":["Medical Scholars Program"],"award-info":[{"award-number":["Medical Scholars Program"]}],"id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","award":["Medical Scholars Program"],"award-info":[{"award-number":["Medical Scholars Program"]}],"id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Syringe services programs (SSPs) are an evidence-based harm reduction strategy that reduces dangerous sequelae of injection drug use among people who inject drugs (PWID) such as overdose. SSP services include safer injection education and community-based naloxone distribution programs. This study evaluates differences in overdose-associated hospital admissions following the implementation of the first legal SSP in Florida, based in Miami-Dade County.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of hospitalizations for injection drug-related sequelae at a county hospital before and after the implementation of the SSP. An algorithm utilizing ICD-10 codes for opioid use and sequelae was used to identify people who inject opioids (PWIO). Florida Department of Law Enforcement Medical Examiners Commission Report data was used to analyze concurrent overdose death trends in Florida counties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over the 25-month study period, 302 PWIO admissions were identified: 146 in the pre-index\u00a0period vs. 156 in the post-index\u00a0period. A total of 26 admissions with PWIO overdose were found: 20 pre-index and 6 post-index (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0034).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Declining overdose-associated admissions among PWIO suggests early impacts following SSP implementation. These results indicate a potential early benefit of SSP that should be further explored for its effects on future hospital admission and mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12954-020-00376-1","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:02:42Z","timestamp":1589248962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hospital admissions among people who inject opioids following syringe services program implementation"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-9184","authenticated-orcid":false,"given":"K. J.","family":"Bornstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Coye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"St. Onge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"5152","key":"376_CR1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419\u201327.","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"376_CR2","volume-title":"Drug identified in deceased persons by Florida medical examiners","author":"Commission ME","year":"2017","unstructured":"Commission ME. Drug identified in deceased persons by Florida medical examiners. Florida Department of Law Enforcement; 2017."},{"key":"376_CR3","unstructured":"Centers for Disease Control and Prevention. HIV surveillance report, 2018 (Preliminary); vol. 30. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Published November 2019. Accessed [1\/31\/2020]."},{"key":"376_CR4","volume-title":"Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug Switzerland: World Health Organization","author":"AC Alex Wodak","year":"2004","unstructured":"Alex Wodak AC, World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug Switzerland: World Health Organization; 2004."},{"key":"376_CR5","unstructured":"Centers for Disease Control and Prevention. Summary of information on the safety and effectiveness of Syringe Services Programs (SSPs) [Available from: https:\/\/www.cdc.gov\/ssp\/syringe-services-programs-summary.html. Accessed 1 Oct 2019."},{"key":"376_CR6","unstructured":"AIDs UN. Do no harm - health, human rights and people who use drugs. 2016 April 15 2016."},{"issue":"1","key":"376_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12954-018-0232-z","volume":"15","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. Harm Reduct J. 2018;15(1):26.","journal-title":"Harm Reduct J."},{"key":"376_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.drugpo.2019.07.010","volume":"73","author":"M Reed","year":"2019","unstructured":"Reed M, Wagner KD, Tran NK, Brady KA, Shinefeld J, Roth A. Prevalence and correlates of carrying naloxone among a community-based sample of opioid-using people who inject drugs. Int J Drug Policy. 2019;73:32\u20135.","journal-title":"Int J Drug Policy."},{"issue":"3","key":"376_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/JAN.0000000000000230","volume":"29","author":"L Chimbar","year":"2018","unstructured":"Chimbar L, Moleta Y. Naloxone effectiveness: a systematic review. J Addict Nurs. 2018;29(3):167\u201371.","journal-title":"J Addict Nurs."},{"key":"376_CR10","unstructured":"Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Centers for Disease Control and Prevention. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morbidity and mortality weekly report. 2015;64(23):631\u20135."},{"issue":"3","key":"376_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/02791072.2018.1430409","volume":"50","author":"AS Bennett","year":"2018","unstructured":"Bennett AS, Bell A, Doe-Simkins M, Elliott L, Pouget E, Davis C. From peers to lay bystanders: findings from a decade of naloxone distribution in Pittsburgh. PA. J Psychoactive Drugs. 2018;50(3):240\u20136.","journal-title":"PA. J Psychoactive Drugs."},{"issue":"1","key":"376_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40621-015-0041-8","volume":"2","author":"RE Giglio","year":"2015","unstructured":"Giglio RE, Li G, DiMaggio CJ. Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis. Inj Epidemiol. 2015;2(1):10.","journal-title":"Inj Epidemiol"},{"issue":"7","key":"376_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177\u201387.","journal-title":"Addiction."},{"issue":"4","key":"376_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/dar.12523","volume":"37","author":"A Olsen","year":"2018","unstructured":"Olsen A, McDonald D, Lenton S, Dietze PM. Assessing causality in drug policy analyses: How useful are the Bradford Hill criteria in analysing take-home naloxone programs? Drug Alcohol Rev. 2018;37(4):499\u2013501.","journal-title":"Drug Alcohol Rev."},{"key":"376_CR15","unstructured":"Alvarez L. Florida shutting \u2018pill mill\u2019 clinics. The New York Times. 2011."},{"issue":"6","key":"376_CR16","doi-asserted-by":"publisher","first-page":"e0129360","DOI":"10.1371\/journal.pone.0129360","volume":"10","author":"H Tookes","year":"2015","unstructured":"Tookes H, Diaz C, Li H, Khalid R, Doblecki-Lewis S. A cost analysis hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami. Florida. PLoS One. 2015;10(6):e0129360.","journal-title":"Florida. PLoS One."},{"issue":"10","key":"376_CR17","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","volume":"175","author":"L Rutkow","year":"2015","unstructured":"Rutkow L, Chang H-Y, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Internal Medicine. 2015;175(10):1642\u20139.","journal-title":"JAMA Internal Medicine."},{"key":"376_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","volume":"55","author":"C Keane","year":"2018","unstructured":"Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: results of an agent-based model. Int J Drug Policy. 2018;55:61\u20139.","journal-title":"Int J Drug Policy."},{"key":"376_CR19","unstructured":"BCHD. Jurisdictional plan for HIV prevention in Baltimore City. Baltimore City; 2012. 2015."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-020-00376-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-020-00376-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T20:00:53Z","timestamp":1620763253000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-020-00376-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1186\/s12954-020-00376-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.24784\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.24784\/v1","asserted-by":"object"}]},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the University of Miami Institutional Review Board (IRB #20180242) and the Jackson Health System Clinical Research Review Committee. Informed consent was not obtained from participants, and a consent waiver was granted. Data were de-identified prior to analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}